St. Josef-Hospital

At St. Josef-Hospital in Bochum, a major share of the clinical research focuses on skin and connective tissue diseases, especially hidradenitis suppurativa, atopic dermatitis, and cutaneous lupus erythematosus. These studies are designed to evaluate new treatment options, improve symptom control, and better understand how inflammatory skin conditions can be managed over time.

• Testing new therapies for moderate-to-severe hidradenitis suppurativa
• Evaluating treatment effectiveness in atopic dermatitis
• Assessing therapies for cutaneous lupus erythematosus
• Studying long-term safety and tolerability in chronic inflammatory skin disease

The department’s work reflects a strong interest in helping patients with persistent, hard-to-treat skin disorders through more effective and better-tolerated care.

A particularly active area at this hospital/clinic is hidradenitis suppurativa, with multiple trials exploring different investigational approaches for people living with this painful and recurring condition. The overall goal is to reduce disease activity, improve skin lesions, and expand treatment choices for patients with moderate to severe disease.

• Measuring whether new therapies improve hidradenitis suppurativa symptoms
• Comparing active treatments with placebo to confirm benefit
• Looking at safety, tolerability, and longer-term use
• Supporting better control of inflammation and skin damage

Research in this field includes both short-term effectiveness studies and longer follow-up evaluations, showing a broad commitment to advancing care for this challenging inflammatory disease.

The site also conducts research in nervous system diseases, with trials in multiple sclerosis, including relapsing, progressive, and primary progressive forms. These studies aim to slow disability progression, improve disease control, and test whether newer immune-targeted treatments can offer added benefit for patients.

• Evaluating treatments for relapsing multiple sclerosis
• Studying options for primary progressive multiple sclerosis
• Assessing approaches for progressive forms of multiple sclerosis
• Exploring ways to delay worsening disability

This research area highlights the St. Josef-Hospital contribution to neuroimmunology, with a focus on meaningful long-term outcomes for people affected by chronic neurological disease.

Clinical research at the site includes important work in neoplasms, especially colorectal cancer, melanoma, and cancers of the gastroesophageal junction and pancreas. These trials are generally focused on improving survival, reducing recurrence, and finding more effective treatment strategies for advanced or resected disease.

• Testing new combination treatments for advanced gastrointestinal tumors
• Evaluating adjuvant strategies in stage III colon cancer
• Studying treatment approaches for melanoma after surgery or in advanced disease
• Assessing therapies for pancreatic cancer and gastroesophageal adenocarcinoma

The oncology portfolio reflects a strong interest in both immunotherapy and treatment optimization, aiming to improve outcomes for patients with difficult-to-treat cancers.

The site is also involved in studies of cardiovascular diseases, particularly heart failure with preserved or mildly reduced ejection fraction, often alongside obesity and systemic inflammation. These trials are designed to see whether new therapies can reduce major heart-related events and improve patient outcomes.

• Evaluating therapies for heart failure with preserved ejection fraction
• Studying heart failure with mildly reduced ejection fraction
• Exploring treatment options linked to obesity and inflammation
• Measuring whether new approaches lower cardiovascular risk

This area adds a broader internal medicine dimension to the research program at St. Josef-Hospital, connecting heart health with inflammatory and metabolic disease.

Beyond the main disease areas, the research portfolio includes studies in Alzheimer’s disease, Parkinson’s disease, multiple system atrophy, myasthenia gravis, and acute ischemic stroke. These trials aim to improve symptom management, slow progression, and test whether new treatment strategies can support better neurological outcomes.

• Studying therapies for early symptomatic Alzheimer’s disease
• Evaluating treatment options in Parkinson’s disease and multiple system atrophy
• Assessing care for generalized myasthenia gravis
• Testing acute treatment strategies in ischemic stroke

These studies show a wide-ranging interest in both chronic neurodegenerative conditions and urgent neurological care.

The site’s portfolio also includes trials in respiratory tract diseases and immune system diseases, such as respiratory tract infections with wheezing and chronic spontaneous urticaria. The purpose of this research is to improve prevention, control inflammation, and support better treatment options for patients with recurrent or immune-mediated conditions.

• Investigating ways to reduce recurrent respiratory tract infections
• Studying treatment options for chronic spontaneous urticaria
• Exploring immune-targeted approaches for inflammatory disease
• Assessing whether new therapies can improve daily symptom burden

Together, these studies broaden the clinical research profile at St. Josef-Hospital beyond dermatology alone, while still emphasizing inflammatory and immune-mediated disease.